- category:Archives
Archives
Hello 2023 — Weekly Glance
Archives
Can we treat uveitis without steroids? — Weekly Glance
New phase 2 data may have the answer.Archives
Can I have one dilation drop instead of two? — Weekly Glance
Maybe! The FDA just accepted a new NDA application.Archives
Are those dilation reversal drops available yet? — Weekly Glance
Not quite, but we have an update!Archives
What's new in the glaucoma world? — Weekly Glance
We may have a new glaucoma drop next year.Archives
Are there any new dry eye treatments on the horizon? — Weekly Glance
There are! Aldeyra Therapeutics just submitted an NDA to the FDA.Archives
Are there any modifiable risk factors for dementia? — Weekly Glance
New research points to vision impairment as a culprit.Archives
AMD and cardiovascular disease. — Weekly Glance
Specific forms of age-related macular degeneration may lead to a higher risk for underlying heart damage.Archives
New FDA approval for a diabetic retinopathy screening tool. — Weekly Glance
AEYE Health has received FDA clearance to market its diagnostic screening system for diabetic retinopathy.Archives
One more reason not to smoke. — Weekly Glance
New research identifies the role of smoking in glaucoma development.Archives
Positive results for myopia control study.— Weekly Glance
Update from Vyluma's phase 3 study!Archives
Will my baby's eyes stay blue..? — Weekly Glance
A recent study says maybe ... maybe not.Archives
Consider it accepted — Weekly Glance
Novaliq has a major update on its new dry eye treatment.Archives
Are there any vision risks associated with PRP aesthetic skin treatments? — Weekly Glance
A literature review study has some answers.Archives
Is AI better at detecting retinopathy than an ophthalmologist? — Weekly Glance
A new study offers an answer.Archives
Is there another way to treat amblyopia besides patching? — Weekly Glance
The FDA just cleared a new digital therapy device.Archives
Normal-tension glaucoma and Alzheimer's disease risk — Weekly Glance
New research points to significant risk factors.Archives
Is there a new glaucoma medication on the market?— Weekly Glance
A new FDA-approved drug is here!Archives
Ocular anesthetic gets FDA approval — Weekly Glance
Proparacaine has an opponent.Archives